To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter Study
Not yet recruitingOBSERVATIONAL
Enrollment
2,000
Participants
Timeline
Start Date
May 1, 2024
Primary Completion Date
March 30, 2025
Study Completion Date
February 1, 2026
Conditions
Acute-On-Chronic Liver Failure
Interventions
OTHER
No intervention in this study
No intervention in this study
All Listed Sponsors
lead
Nanfang Hospital, Southern Medical University
OTHER
NCT06377774 - To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter Study | Biotech Hunter | Biotech Hunter